GammaCan International, Inc. Announces Appointment Of Richard Spritz, M.D. To Scientific Advisory Board; Leading Geneticist And Pediatric Specialist To Assist Company In Researching And Achieving Milestones In Its Efforts To Bring VitiGam To The Clinic

KIRYAT ONO, Israel & NEW YORK--(BUSINESS WIRE)--Sept. 5, 2006--GammaCan International (OTCBB: GCAN) today announced the appointment of Richard Spritz, M.D. to the Company's Scientific Advisory Board. Bringing over thirty years of medical and scientific acumen to GammaCan, and specifically to the Company's mission of bringing VitiGam to the clinic, Dr. Spritz is a member of the Medical Advisory Board of Vitiligo Support International and a Council Member of PanAmerican Pigment Cell Society.